Medical Countermeasures New Mutation and DNA Repeats Behind Ceftazidime Resistance in Melioidosis BacteriumGlobal Biodefense StaffSeptember 5, 2025
Medical Countermeasures Appili Therapeutics Reports Strong Preclinical Protection from ATI-1701 Tularemia VaccineGlobal Biodefense StaffAugust 11, 2025
Medical Countermeasures Pan-Coronavirus Drug Discovery Gets a Boost from Global AI Blind ChallengeGlobal Biodefense StaffJuly 28, 2025
MGB Biopharma Receives 6.4M to Advance Novel Antibacterial Antimicrobial Resistance September 18, 2014 …
Antimicrobial Strategy Silences Resistant Gene in Pathogens Antimicrobial Resistance September 8, 2014 …